Authors
Dominador V Del Castillo, Yan Wang
Published in
JACC. Case reports. Volume 31. Issue 45. Pages 110544. Nov 11, 2026.
Abstract
To describe a heart team-driven staged transcatheter strategy for accelerated triple bioprosthetic valve failure in a patient with prohibitive surgical risk.
A 78-year-old woman with systemic lupus erythematosus, stage 4 chronic kidney disease, permanent atrial fibrillation, and severe frailty presented with NYHA functional class III heart failure. She had undergone triple surgical bioprosthetic heart valve replacement 8 years earlier. Imaging demonstrated severe aortic, mitral, and tricuspid bioprosthetic valve failure. Given prohibitive surgical risk, a staged transcatheter strategy was selected. Valve-in-valve transcatheter aortic valve replacement with a 23-mm supra-annular self-expanding valve and bioprosthetic valve fracture was performed first, followed by valve-in-valve (ViV)-transcatheter mitral valve replacement and ViV transcatheter tricuspid valve replacement with 26-mm balloon-expandable valves. All procedures were successful without complications. At 2 months, NYHA functional class improved from III to II, with satisfactory function of all 3 valves.
Coronary obstruction, patient-prosthesis mismatch, neo-left ventricular outflow tract obstruction, and hemodynamic intolerance.
Staged triple ViV intervention may provide a feasible alternative to redo surgery. Multimodality imaging and individualized sequencing are critical.
PMID:
43018208
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0